N/A N=93 Randomized Single-blind Treatment

Recovery After Stress Toolkit (RESET) Study

Post-Traumatic Stress Disorder in Children · Post-Traumatic Stress Disorder in Adolescence

Bottom Line

View on ClinicalTrials.gov: NCT04838977 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2025

Primary outcome: Primary: Child PTSD Symptom Scale (CPSS) — 10.4; 14 Score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: RESET (Behavioral)
Age: Pediatric · 8+ yrs
Sex: All
Sponsor: University of Utah
Primary completion: Jan 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Child PTSD Symptom Scale (CPSS)	10.4; 14	—
SECONDARY Screen for Anxiety Related Emotional Disorders (SCARED)	12.6; 20.8	—
SECONDARY Patient Reported Outcome Measurement Information System (PROMIS) Pediatric Depressive Symptoms	42.9; 49.8	—
SECONDARY Pediatric Quality of Life Inventory (PedsQL)	71.4; 68.4	—

Summary

This study evaluates the use of web-based educational modules combined with telehealth delivered therapy for children with post-traumatic stress symptoms (PTSS) after receiving hospital based medical attention for an injury. Half of the participants will received the online therapy and half of the participants will receive usual care.

Eligibility Criteria

Inclusion Criteria

8 years to 17 years at enrollment
Treated for an injury in the ED or hospitalized
Abbreviated Injury Scale (AIS) score 2 or greater
Parent and child English speaking
Broad band internet availability at home
Residing with parent or legal guardian

Exclusion Criteria

Moderate or severe traumatic brain injury (GCS less than 13)
Diagnosed with moderate or severe intellectual disability
Pre-existing psychiatric disorder that required hospitalization
Abuse or interpersonal injury as mechanism of injury
Currently receiving psychotherapy
Hospitalized for injury over 30 ays
Death of a family member or friend at time of injury

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04838977). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.